Literature DB >> 19734234

Quantitating T cell cross-reactivity for unrelated peptide antigens.

Jeffrey Ishizuka1, Kristie Grebe, Eugene Shenderov, Bjoern Peters, Qiongyu Chen, Yanchun Peng, Lili Wang, Tao Dong, Valerie Pasquetto, Carla Oseroff, John Sidney, Heather Hickman, Vincenzo Cerundolo, Alessandro Sette, Jack R Bennink, Andrew McMichael, Jonathan W Yewdell.   

Abstract

Quantitating the frequency of T cell cross-reactivity to unrelated peptides is essential to understanding T cell responses in infectious and autoimmune diseases. Here we used 15 mouse or human CD8+ T cell clones (11 antiviral, 4 anti-self) in conjunction with a large library of defined synthetic peptides to examine nearly 30,000 TCR-peptide MHC class I interactions for cross-reactions. We identified a single cross-reaction consisting of an anti-self TCR recognizing a poxvirus peptide at relatively low sensitivity. We failed to identify any cross-reactions between the synthetic peptides in the panel and polyclonal CD8+ T cells raised to viral or alloantigens. These findings provide the best estimate to date of the frequency of T cell cross-reactivity to unrelated peptides ( approximately 1/30,000), explaining why cross-reactions between unrelated pathogens are infrequently encountered and providing a critical parameter for understanding the scope of self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734234      PMCID: PMC2762195          DOI: 10.4049/jimmunol.0901607

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

Authors:  Weisan Chen; Kelly-Anne Masterman; Sameh Basta; S M Mansour Haeryfar; Nektaria Dimopoulos; Barbara Knowles; Jack R Bennink; Jonathan W Yewdell
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

3.  HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.

Authors:  R P Johnson; A Trocha; L Yang; G P Mazzara; D L Panicali; T M Buchanan; B D Walker
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Authors:  Carla Oseroff; Ferdynand Kos; Huynh-Hoa Bui; Bjoern Peters; Valerie Pasquetto; Jean Glenn; Tara Palmore; John Sidney; David C Tscharke; Jack R Bennink; Scott Southwood; Howard M Grey; Jonathan W Yewdell; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

5.  T cell cross-reactivity and conformational changes during TCR engagement.

Authors:  Jean K Lee; Guillaume Stewart-Jones; Tao Dong; Karl Harlos; Kati Di Gleria; Lucy Dorrell; Daniel C Douek; P Anton van der Merwe; E Yvonne Jones; Andrew J McMichael
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

6.  Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.

Authors:  Lydie Trautmann; Marie Rimbert; Klara Echasserieau; Xavier Saulquin; Bérangère Neveu; Julie Dechanet; Vincenzo Cerundolo; Marc Bonneville
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

7.  The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.

Authors:  Jeffrey Ishizuka; Guillaume B E Stewart-Jones; Anton van der Merwe; John I Bell; Andrew J McMichael; E Yvonne Jones
Journal:  Immunity       Date:  2008-02       Impact factor: 31.745

8.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

9.  Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.

Authors:  F Gotch; A McMichael; G Smith; B Moss
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.

Authors:  W W Overwijk; A Tsung; K R Irvine; M R Parkhurst; T J Goletz; K Tsung; M W Carroll; C Liu; B Moss; S A Rosenberg; N P Restifo
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  44 in total

1.  The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants.

Authors:  Galina V Petrova; Elena N Naumova; Jack Gorski
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes.

Authors:  R S Abidin; L H L Lua; A P J Middelberg; F Sainsbury
Journal:  Protein Sci       Date:  2015-10-07       Impact factor: 6.725

Review 3.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

4.  Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.

Authors:  Cameron J Turtle; Jeff Delrow; Rochelle C Joslyn; Hillary M Swanson; Ryan Basom; Laura Tabellini; Colleen Delaney; Shelly Heimfeld; John A Hansen; Stanley R Riddell
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

5.  Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.

Authors:  Karim M Abdel-Hady; Andres H Gutierrez; Frances Terry; Joe Desrosiers; Anne S De Groot; Hassan M E Azzazy
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens.

Authors:  Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

7.  Driving forces of proteasome-catalyzed peptide splicing in yeast and humans.

Authors:  Michele Mishto; Andrean Goede; Kathrin Textoris Taube; Christin Keller; Katharina Janek; Petra Henklein; Agathe Niewienda; Alexander Kloss; Sabrina Gohlke; Burkhardt Dahlmann; Cordula Enenkel; Peter Michael Kloetzel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

Review 8.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 9.  Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.

Authors:  Javeed A Shah; Cecilia S Lindestam Arlehamn; David J Horne; Alessandro Sette; Thomas R Hawn
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

10.  Concept and application of a computational vaccinology workflow.

Authors:  Johannes Söllner; Andreas Heinzel; Georg Summer; Raul Fechete; Laszlo Stipkovits; Susan Szathmary; Bernd Mayer
Journal:  Immunome Res       Date:  2010-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.